![](/img/cover-not-exists.png)
P-949 Phase II pharmacodynamic trial of erlotinib in advancednon-small cell lung cancer (NSCLC) patients previously treated with platinum-based chemotherapy
Felip, E., Rojo, F., Heller, A., Foernzler, D., Majo, J., Klughammer, B., Ramos, J., Maacke, H., Brennscheidt, U., Baselga, J.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(05)81442-4
Date:
July, 2005
File:
PDF, 144 KB
english, 2005